Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Supply disruption alert issued for various brands of oral contraceptive tablets

The Department of Health and Social Care (DH) has issued a medicine supply notification for oral contraceptive tablets of various brands.

The following oral contraceptive preparations are currently out of stock.


Product affectedIngredientsAnticipated Resupply DateManagement Advice
DianetteEthinylestradiol 35microgram/ Cyproterone 2mg tabletsw/c 26 April 2021Equivalent alternatives remain available from the following manufacturers; Strandhaven Ltd, Stragen UK Ltd and Kent Pharma.
FemodetteEthinylestradiol 20microgram / Gestodene 75microgram tabletsw/c 03 May 2021Equivalent alternatives remain available from suppliers of the following brands: Akizza, Millinette and Sunya
NorgestonLevonorgestrel 30mg tabletsw/c 19 April 2021 – w/c 31 May 2021No exact equivalent available in the UK market. Unlicensed imports have been sourced, lead times vary.
Norinyl-1Mestranol 50microgram / Norethisterone 1mg tabletsw/c 22 March 2021No exact equivalent available in the UK market. Unlicensed imports have been sourced, lead times vary.
QlairaEstradiol Valerate / Dienogest (various strengths)w/c 25 October 2021No exact equivalent available in the UK market.
YiznellEthinylestradiol/drospirenone 30microgram/3mg tabletsw/c 29 March 2021Equivalent alternatives with same composition remain available from suppliers of following brands: Dretine, Yacella,  Ellaite and Lucette.
Yasminw/c 3 May 2021 – w/c 5 July 2021

Target Healthcare and Smartway Pharma have confirmed that they can source unlicensed imports of Mestranol 50 microgram / Norethisterone 1mg (Norinyl-1 equivalent) tablets.

Smartway Pharma has assured that it can source unlicensed imports of Levonorgestrel 30mg (Norgeston equivalent) tablets and Estradiol Valerate / Dienogest (Qlaira equivalent) tablets.

If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems  an EPS prescription for unlicensed product cannot be issued.

Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Required Product (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.